Knee Pain. Osteoarthritis of knee, unspecified
Conditions
Interventions
Intervention group:.
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to No maximum
Inclusion criteria
Inclusion criteria: Complete vigilance and satisfaction. Age over 35 years old. Diagnosis of osteoarthritis according to the American Society of Rheumatology: Having knee pain and having at least 5 of the 8 cases Not using a variety of complementary therapies during the previous three months Lack of personalized sedative medications and drug by the patient The absence of severe neuropathy in the patient. Healthy areas under massage Lack of mental retardation, blindness and deafness. The absence of rheumatoid arthritis, fibromyalgia, acute or recurrent pseudoravirus, malignancy, internal disease, Such as kidney or liver disorder, gastrointestinal bleeding, asthma requiring corticosteroid administration Non-use of corticosteroid in less than 5 weeks, injection of knee depoocorticosteroid in less than 3 months old or intra-articular hyaluronate in less than 6 months A lack of arthroscopy over the past year No significant damage to the knee in less than 6 months Insensitivity and ulcer in the knee. Ability to learn 12 ghams points
Exclusion criteria
Exclusion criteria: Using a variety of complementary therapies during the previous three months Personalized sedative medications and drug by the patient Severe neuropathy in the patient Having mental retardation, blindness and deafness. having the rheumatoid arthritis, fibromyalgia, acute or recurrent pseudoravirus, malignancy, internal disease, Such as kidney or liver disorder, gastrointestinal bleeding, asthma requiring corticosteroid administration Use of corticosteroid in less than 5 weeks, injection of knee depoocorticosteroid in less than 3 months old or intra-articular hyaluronate in less than 6 months Arthroscopy over the past year Significant damage to the knee in less than 6 months Sensitivity and ulcer in the knee
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Knee Pain. Timepoint: Before the study 0, Sixth day, Fourteenth day. Method of measurement: Knee injury and Osteoarthritis Outcome Score, Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Diclofenac drug intake. Timepoint: Fourteenth day. Method of measurement: Number. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Alinaghizadeh
Tehran University of Medical Sciences
Outcome results
None listed